DK1767216T3 - Lægemiddel med regulatorisk celleligand indeholdt i liposom - Google Patents

Lægemiddel med regulatorisk celleligand indeholdt i liposom

Info

Publication number
DK1767216T3
DK1767216T3 DK05750814.5T DK05750814T DK1767216T3 DK 1767216 T3 DK1767216 T3 DK 1767216T3 DK 05750814 T DK05750814 T DK 05750814T DK 1767216 T3 DK1767216 T3 DK 1767216T3
Authority
DK
Denmark
Prior art keywords
liposome
drug contained
ligand drug
regulatory cell
cell ligand
Prior art date
Application number
DK05750814.5T
Other languages
English (en)
Inventor
Yasuyuki Ishii
Risa Nozawa
Masaru Taniguchi
Original Assignee
Riken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riken filed Critical Riken
Application granted granted Critical
Publication of DK1767216T3 publication Critical patent/DK1767216T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK05750814.5T 2004-06-11 2005-06-03 Lægemiddel med regulatorisk celleligand indeholdt i liposom DK1767216T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004173844 2004-06-11
JP2004313830 2004-10-28
PCT/JP2005/010254 WO2005120574A1 (ja) 2004-06-11 2005-06-03 調節性細胞リガンドをリポソームに含有させてなる医薬

Publications (1)

Publication Number Publication Date
DK1767216T3 true DK1767216T3 (da) 2012-09-03

Family

ID=35502836

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05750814.5T DK1767216T3 (da) 2004-06-11 2005-06-03 Lægemiddel med regulatorisk celleligand indeholdt i liposom

Country Status (11)

Country Link
US (3) US20070104776A1 (da)
EP (1) EP1767216B1 (da)
JP (1) JP4889485B2 (da)
KR (1) KR101215808B1 (da)
CN (1) CN1997395B (da)
AU (1) AU2005251589B2 (da)
CA (1) CA2569590C (da)
DK (1) DK1767216T3 (da)
ES (1) ES2389080T3 (da)
PT (1) PT1767216E (da)
WO (1) WO2005120574A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010051156A1 (en) * 2000-04-28 2001-12-13 Defu Zeng Methods for inhibition of polyclonal B cell activation and immunoglobulin class switching to pathogenic autoantibodies by blocking CD1-mediated interactions
US7419958B2 (en) * 2001-03-26 2008-09-02 Dana-Farber Cancer Institute, Inc. Method of attenuating reactions to skin irritants
CN101031307B (zh) * 2004-11-02 2012-09-05 小利兰斯坦福大学托管委员会 抑制nkt细胞的制药用途
JP5191234B2 (ja) * 2006-01-13 2013-05-08 独立行政法人理化学研究所 免疫疾患の予防ないし治療剤および方法
WO2007100154A1 (ja) * 2006-03-03 2007-09-07 Riken アレルギー疾患に対する制御性樹状細胞を用いた免疫細胞療法
JP5564672B2 (ja) 2006-06-30 2014-07-30 ザ スクリプス リサーチ インスティテュート アジュバント及びその使用方法
EP2711020B1 (en) 2008-05-02 2016-08-10 BliNK Therapeutics Limited Products and methods for stimulating an immune response
EP2435092A2 (en) 2009-05-27 2012-04-04 Selecta Biosciences, Inc. Nanocarriers possessing components with different rates of release
ES2661978T3 (es) 2010-05-26 2018-04-04 Selecta Biosciences, Inc. Vacunas multivalentes de nanovehículos sintéticos
CN109172819A (zh) 2011-07-29 2019-01-11 西莱克塔生物科技公司 产生体液和细胞毒性t淋巴细胞（ctl）免疫应答的合成纳米载体
EP2889039B1 (en) 2012-08-22 2017-11-08 Regimmune Corporation Preparation for preventing or treating type i diabetes
US20150283235A1 (en) * 2012-11-05 2015-10-08 Regimmune Corporation Immune-tolerance inducer
TW201442739A (zh) * 2013-02-27 2014-11-16 Riken 過敏疾病治療藥
CN104623646B (zh) * 2013-11-11 2018-05-18 广西医科大学 一种双功能配体靶向树突状细胞肿瘤疫苗及其制备方法
MX2016009217A (es) * 2014-01-17 2017-05-12 Fundació Inst D'investigació En Ciències De La Salut Germans Trias I Pujol Inmunoterapia basada en liposomas.
US20190000760A1 (en) 2015-12-07 2019-01-03 Regimmune Corporation Nanoparticle-aqueous dispersion liquid of glycosphingolipid
EP3603619A4 (en) * 2017-03-29 2020-12-09 Sumitomo Dainippon Pharma Co., Ltd. VACCINAL ADJUVANT FORMULATION
WO2018222989A1 (en) * 2017-06-02 2018-12-06 The Penn State Research Foundation Ceramide nanoliposomes, compositions and methods of using for immunotherapy
US11554178B2 (en) * 2017-06-30 2023-01-17 City Of Hope Compositions and methods of modulating macrophage activity
JPWO2019103151A1 (ja) * 2017-11-27 2021-01-21 国立大学法人千葉大学 核酸を細胞内に送達するための脂質膜構造体
CN109512804A (zh) * 2019-01-21 2019-03-26 上海交通大学医学院附属仁济医院 神经酰胺c6在制备治疗胆囊癌的药物中的用途
CN112089832B (zh) * 2020-09-25 2022-04-22 江南大学 一种半抗原修饰的载体蛋白及其在制备疫苗中的应用
US20230414507A1 (en) 2020-12-04 2023-12-28 Regimmune Corporation Cd1d-ligand-compound-containing liposome preparation having improved pharmacokinetics

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416872A (en) * 1982-03-17 1983-11-22 The United States Of America As Represented By The Secretary Of The Army Treatment of malaria with liposomes containing 8-aminoquinoline derivatives and glycoconjugates
JP2588729B2 (ja) 1987-10-05 1997-03-12 塩野義製薬株式会社 スフィンゴシン誘導体
US5043165A (en) * 1988-12-14 1991-08-27 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs
DE4322330A1 (de) * 1992-08-31 1994-03-03 Behringwerke Ag Verwendung des IL-4-Rezeptors zur Therapie, Prophylaxe und Diagnose von allergischen, viralen, parasitären und bakteriellen Erkrankungen sowie von Pilzinfektionen
JP3800434B2 (ja) * 1994-05-31 2006-07-26 生化学工業株式会社 擬似糖脂質
CA2150613A1 (en) * 1994-05-31 1995-12-01 Seiichiro Ogawa Glycolipid analogs
JP2896321B2 (ja) * 1994-10-27 1999-05-31 鐘紡株式会社 β−グルコセレブロシダーゼの活性化方法
AU6793598A (en) * 1997-03-31 1998-10-22 University Of Iowa Research Foundation, The Glycosylceramide-containing liposomes
ES2318236T3 (es) 1997-04-10 2009-05-01 Kyowa Hakko Kirin Co., Ltd. Agentes activadores de celulas nkt que contienen alfa-glucosilceramidas.
WO1999033475A1 (en) * 1997-12-30 1999-07-08 A+ Science Invest Ab Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications
JPH11302155A (ja) * 1998-04-24 1999-11-02 La Shinshia Kk アトピー性皮膚炎のための皮膚外用剤
US20030087851A1 (en) * 1999-01-20 2003-05-08 Biozak, Inc. Pharmaceutical composition for treating or preventing influenza, and novel oligonucleotide
US20020031787A1 (en) * 2000-02-04 2002-03-14 Maclaren Noel K. Compositions and methods for reducing autoimmunity
AU2001268564A1 (en) * 2000-06-22 2002-01-02 The Brigham And Women's Hospital, Inc. Alpha-glycosylceramides for treating bacterial and fungal infections
DE10041515A1 (de) * 2000-08-24 2002-03-14 Gerold Schuler Verfahren zur Herstellung gebrauchsfertiger, Antigen-beladener oder -unbeladener, kryokonservierter reifer dendritischer Zellen
GB0105360D0 (en) * 2001-03-03 2001-04-18 Glaxo Group Ltd Chimaeric immunogens
AU2002247847A1 (en) * 2001-04-09 2002-10-21 Lorantis Limited Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways
JP4714368B2 (ja) * 2001-05-24 2011-06-29 独立行政法人理化学研究所 スフィンゴ脂質合成のコンディショナルノックアウト哺乳動物
EP1434859A2 (en) * 2001-07-25 2004-07-07 New York University Use of glycosylceramides as adjuvants for vaccines against infections and cancer
EP1572114A2 (en) 2002-09-27 2005-09-14 Biomira, Inc. Glycosylceramide analogues
AU2003269268A1 (en) * 2002-10-09 2004-05-04 Lorantis Limited Modulation of immune function

Also Published As

Publication number Publication date
KR20070026796A (ko) 2007-03-08
CA2569590C (en) 2014-04-01
KR101215808B1 (ko) 2012-12-26
WO2005120574A1 (ja) 2005-12-22
EP1767216A4 (en) 2008-09-03
US8920774B2 (en) 2014-12-30
ES2389080T3 (es) 2012-10-23
JP4889485B2 (ja) 2012-03-07
EP1767216B1 (en) 2012-07-11
JPWO2005120574A1 (ja) 2008-04-03
CA2569590A1 (en) 2005-12-22
CN1997395B (zh) 2012-08-29
US9387170B2 (en) 2016-07-12
CN1997395A (zh) 2007-07-11
US20150071991A1 (en) 2015-03-12
EP1767216A1 (en) 2007-03-28
US20070104776A1 (en) 2007-05-10
US20100104632A1 (en) 2010-04-29
AU2005251589B2 (en) 2011-01-06
PT1767216E (pt) 2012-08-27
AU2005251589A1 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
DK1767216T3 (da) Lægemiddel med regulatorisk celleligand indeholdt i liposom
DE602005006442D1 (de) Batterierestkapazitätsmesser
DE602005017745D1 (de) Brennstoffzellen-auseinanderbauverfahren
DE602005022766D1 (de) Batteriehülle
DE602005024010D1 (de) Behälter
DE602005025931D1 (de) Brennstoffzelle
DK1711188T3 (da) Anticancerterapier
DE602005023645D1 (de) Brennstoffzellenseparator
AT500095B8 (de) Transdermales abgabesystem
DE602005022581D1 (de) Brennstoffzelle
DE502005007117D1 (de) Dosierpumpe
DE602005004061D1 (de) Brennstoffzelleneinheit
FI20040601A (fi) Lastenistuin käytettäväksi ajoneuvossa
DE602005010396D1 (de) Brennstoffzelle
DE602005017686D1 (de) Brennstoffzelle
ITTO20040494A1 (it) Container telonato
SE0402778L (sv) Stol
GB0500698D0 (en) Ligands for use in homogeneous catalysis
FI20045499A0 (fi) Järjestely oskillointilaitteessa
EE200700004A (et) Pööratav rullkonteiner
SE0402454D0 (sv) Container with dividing means
SE0400969D0 (sv) Aryl glycine derivatives and their use
SE0400118D0 (sv) Kontrollorgan för räkneverk i dosräknare
UA10458S (uk) Бак акумуляторний
UA10456S (uk) Бак акумуляторний